16/01/2013

ESTEVE AND FARMAMUNDI RENEWED THEIR COMMITMENT TO THE MOST DISADVANTAGED PEOPLE

In 2012, ESTEVE collaborated in providing healthcare and food for more than 64,000 people in Haiti, the Dominican Republic, Mali, Uganda, the Democratic Republic of the Congo, Syria, Palestine, Senegal, El Salvador and Guatemala.

ESTEVE and the NGO Farmamundi have just renewed, for 2013, the cooperation agreement they've had since 2005 which promotes humanitarian aid to attend to emergency situations in the most disadvantaged communities. In 2013, ESTEVE has broadened and strengthened its collaboration with Farmamundi's Humanitarian and Emergency Aid Fund (FAHE) via financial and drug donations, as well as concentrating all its donations of medicines through this NGO. During 2012, support was provided for actions in ten countries, benefitting more than 64,000 people.

By renewing the agreement for 2013, ESTEVE and Farmamundi have consolidated their relationship, with a significant innovation: for the first time, the company has concentrated all its donations of medicines through Farmamundi to "encourage and reinforce the construction of a global drug donation system that is more robust and based on good practices, optimising resources and increasing professionalism, cooperation and especially transparency" notes Sílvia Gil-Vernet, ESTEVE's Director of Sustainability. All this with the aim of guaranteeing, at all times, compliance of the World Health Organisation guidelines (WHO) and the provisions of the Spanish Drug Agency (AEMPS).

More than 64,000 people have benefitted

Thanks to this agreement, last year assistance was given to families in Haiti and the Dominican Republic affected by Hurricane Sandy, as well as eight fishing villages around Lake Albert in Kibaale, Uganda, providing treatments and carrying out actions to prevent and control cholera, and also providing healthcare for disabled children and youngsters in the Askar refugee camp in the Palestinian town of Nablus.

ESTEVE also took part in different actions to ensure food security and help prevent malaria for the displaced people in the Ségou Region and Nara Cercle (Mali), also providing healthcare and food for families affected by the recent earthquake in Guatemala, in the department of Quetzaltenango, one of the hardest hit, as well as emergency aid to combat the dengue fever epidemic in the municipality of El Carmen in El Salvador. It also supported work in Senegal providing healthcare for people forced out of their homes by floods.

Reinforcing and continuing this cooperation agreement helps to create new synergies between ESTEVE and Farmamundi, particularly in terms of making the right to health more universal and improving access to medicines. It also advances the vision and strategy of Corporate Social Responsibility (CSR) being developed by the company. "Renewing and extending this agreement is another step forward in the commitment and responsibilities upheld by ESTEVE since it was founded in terms of improving people's health and quality of life, as well as improving access to medicines in the most impoverished communities" states Gil-Vernet.

Farmamundi manages all the medical and pharmaceutical material donated by ESTEVE in response to the needs of the affected communities, either directly or through the institutions and entities we collaborate with. Ricard Troiano, Farmamundi's representative in Catalonia, points out that "Farmamundi aims to engage Spanish firms like ESTEVE and bolster future long-term collaboration in order to have the funds to attend to any emergency with the greatest effectiveness and as quickly as possible.

For more information, see its Sustainability Report at: www.esteve.com You can follow ESTEVE on Twitter via this link: twitter.com/esteve_news.

Last news

  • ESTEVE APPOINTS JORDI MUNTAÑOLA AS CHIEF COMMERCIAL OFFICER FOR EUROPE

    Jordi Muntañola will take on the leadership of all the pharmaceutical activities in Spain and Europe

    read more
  • POMPEU FABRA UNIVERSITY AND ESTEVE ARE TO INVESTIGATE NEW TARGETS FOR TREATING NEUROPATHIC PAIN

    The RIBOPAIN project aims to identify new therapeutic solutions for pain and to develop more effective drugs

    read more
  • ESTEVE ANNOUNCES A RESTRUCTURING OF ITS PHARMACEUTICAL ACTIVITY

    Esteve Pharmaceuticals submits a reduction in force (RIF) which will affect 103 jobs in Spain

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.